Published in Radiology on October 01, 2008
Renal angiomyolipoma: a radiological classification and update on recent developments in diagnosis and management. Abdom Imaging (2014) 1.25
Renal mass biopsy to guide treatment decisions for small incidental renal tumors: a cost-effectiveness analysis. Radiology (2010) 1.07
Public attitudes toward ancillary information revealed by pharmacogenetic testing under limited information conditions. Genet Med (2011) 1.06
Biopsy of renal masses: when and why. Cancer Imaging (2009) 1.04
Small renal masses: incidental diagnosis, clinical symptoms, and prognostic factors. Adv Urol (2009) 1.00
Imaging renal cell carcinoma with ultrasonography, CT and MRI. Nat Rev Urol (2010) 0.94
DNA methylation profiling reveals novel diagnostic biomarkers in renal cell carcinoma. BMC Med (2014) 0.92
Solid renal masses: what the numbers tell us. AJR Am J Roentgenol (2014) 0.90
Imaging findings of common benign renal tumors in the era of small renal masses: differential diagnosis from small renal cell carcinoma: current status and future perspectives. Korean J Radiol (2015) 0.89
CT Hounsfield numbers of soft tissues on unenhanced abdominal CT scans: variability between two different manufacturers' MDCT scanners. AJR Am J Roentgenol (2014) 0.88
Assessment and characterisation of common renal masses with CT and MRI. Insights Imaging (2011) 0.86
Dual energy MDCT assessment of renal lesions: an overview. Eur Radiol (2013) 0.83
Co-existing sarcoidosis confounds the staging of bilateral renal cell carcinoma. J Radiol Case Rep (2011) 0.82
Dual-energy CT with tin filter technology for the discrimination of renal lesion proxies containing blood, protein, and contrast-agent. An experimental phantom study. Eur Radiol (2010) 0.81
The role of pathology in small renal mass laparoscopic cryoablation. Adv Urol (2012) 0.81
Imaging and management of the incidentally discovered renal mass. Cancer Imaging (2009) 0.80
Bosniak classification of renal cystic lesions according to multidetector computed tomography findings. Radiol Bras (2015) 0.79
Renal granular cell tumour (Abrikossoff tumour): case report and review of the literature. Br J Radiol (2011) 0.79
The role of Bosniak classification in malignant tumor diagnosis: A single institution experience. Investig Clin Urol (2016) 0.76
Journal club: Renal masses detected at abdominal CT: radiologists' adherence to guidelines regarding management recommendations and communication of critical results. AJR Am J Roentgenol (2014) 0.76
Safety and feasibility of radiofrequency ablation for treatment of Bosniak IV renal cysts. Int Braz J Urol (2016) 0.76
Imaging and Management of Incidental Renal Lesions. Biomed Res Int (2017) 0.75
Management of incidental renal masses: Time to consider contrast-enhanced ultrasonography. Ultrasound (2016) 0.75
Fat-poor angiomyolipoma with cyst-like changes mimicking a cystic renal cell carcinoma: a case report. World J Surg Oncol (2015) 0.75
Incidental solid cystic renal lesion. Cancer Imaging (2012) 0.75
Magnetic Resonance Imaging and the Use in Small Renal Masses. Indian J Surg Oncol (2016) 0.75
CUA guideline on the management of cystic renal lesions. Can Urol Assoc J (2017) 0.75
Comparison between computed tomography multislice and high-field magnetic resonance in the diagnostic evaluation of patients with renal masses. Quant Imaging Med Surg (2015) 0.75
Diagnostic potential of multidetector computed tomography for characterizing small renal masses. ScientificWorldJournal (2015) 0.75
Evaluation of hyperdense renal lesions incidentally detected on single-phase post-contrast CT using dual-energy CT. Br J Radiol (2016) 0.75
In vivo predictors of renal cyst pseudoenhancement at 120 kVp. AJR Am J Roentgenol (2014) 0.75
Ultrasound-guided genitourinary interventions: principles and techniques. Ultrasonography (2017) 0.75
Renal Masses Detected on FDG PET/CT in Patients With Lymphoma: Imaging Features Differentiating Primary Renal Cell Carcinomas From Renal Lymphomatous Involvement. AJR Am J Roentgenol (2017) 0.75
Gene expression correlates of clinical prostate cancer behavior. Cancer Cell (2002) 16.27
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci U S A (2006) 6.90
Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee. J Am Coll Radiol (2010) 4.15
Renal mass biopsy--a renaissance? J Urol (2007) 3.12
Bladder cancer. J Natl Compr Canc Netw (2013) 2.46
Radical retropubic prostatectomy and robotic-assisted laparoscopic prostatectomy: likelihood of positive surgical margin(s). Urology (2010) 2.31
Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging. Radiology (2009) 1.94
ACR Appropriateness Criteria® acute onset flank pain--suspicion of stone disease. Ultrasound Q (2012) 1.76
Bosniak category IIF and III cystic renal lesions: outcomes and associations. Radiology (2011) 1.74
Neoadjuvant docetaxel before radical prostatectomy in patients with high-risk localized prostate cancer. Clin Cancer Res (2005) 1.68
Predictors of patient preferences and treatment choices for localized prostate cancer. Cancer (2008) 1.66
Renal masses: quantitative analysis of enhancement with signal intensity measurements versus qualitative analysis of enhancement with image subtraction for diagnosing malignancy at MR imaging. Radiology (2004) 1.61
ACR Appropriateness Criteria ® acute onset of scrotal pain--without trauma, without antecedent mass. Ultrasound Q (2012) 1.57
Contrast-to-noise ratio and low-contrast object resolution on full- and low-dose MDCT: SAFIRE versus filtered back projection in a low-contrast object phantom and in the liver. AJR Am J Roentgenol (2012) 1.53
Laparoscopic partial nephrectomy for cystic masses. J Urol (2005) 1.49
MRI of female urethral and periurethral disorders. AJR Am J Roentgenol (2004) 1.47
Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostate. J Clin Oncol (2002) 1.47
Renal tumors: MR imaging-guided percutaneous cryotherapy--initial experience in 23 patients. Radiology (2005) 1.45
Primary retroperitoneal lymph node dissection in patients with clinical stage IS testis cancer. J Urol (2009) 1.44
New frontiers in nanotechnology for cancer treatment. Urol Oncol (2008) 1.42
Diagnostic imaging approach to pulmonary embolism. Cleve Clin J Med (2005) 1.40
Effect of altering automatic exposure control settings and quality reference mAs on radiation dose, image quality, and diagnostic efficacy in MDCT enterography of active inflammatory Crohn's disease. AJR Am J Roentgenol (2010) 1.40
CT findings in acute gangrenous cholecystitis. AJR Am J Roentgenol (2002) 1.39
Incompletely characterized incidental renal masses: emerging data support conservative management. Radiology (2015) 1.39
Imaging for nephron-sparing surgery. Semin Urol Oncol (2002) 1.38
Decision analysis using individual patient preferences to determine optimal treatment for localized prostate cancer. Cancer (2007) 1.37
Development of an integrated prostate cancer research information system. Clin Genitourin Cancer (2006) 1.36
Bladder cancer. J Natl Compr Canc Netw (2009) 1.32
The zinc finger protein ras-responsive element binding protein-1 is a coregulator of the androgen receptor: implications for the role of the Ras pathway in enhancing androgenic signaling in prostate cancer. Mol Endocrinol (2007) 1.20
Evidence to support a continued stage migration and decrease in prostate cancer specific mortality. J Urol (2006) 1.19
Tumor detection by virtual cystoscopy with color mapping of bladder wall thickness. J Urol (2002) 1.16
CT urography for the diagnosis of medullary sponge kidney. Am J Nephrol (2014) 1.14
A critical analysis of the actual role of minimally invasive surgery and active surveillance for kidney cancer. Eur Urol (2009) 1.13
Gonadal vein tumor thrombus in metastatic renal cell carcinoma. Urology (2009) 1.12
Intertubular growth in pure seminomas: associations with poor prognostic parameters. Hum Pathol (2005) 1.10
CT characteristics of primary retroperitoneal neoplasms. Crit Rev Comput Tomogr (2004) 1.08
Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted MR imaging as a stand-alone sequence for diagnosis. Radiology (2006) 1.07
Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer: a Prostate Cancer Clinical Trials Consortium trial. Cancer (2012) 1.07
Urinary calculi: radiation dose reduction of 50% and 75% at CT--effect on sensitivity. Radiology (2009) 1.07
Effect of reduced radiation exposure and iterative reconstruction on detection of low-contrast low-attenuation lesions in an anthropomorphic liver phantom: an 18-reader study. Radiology (2014) 1.06
Changing prostate-specific antigen outcome after surgery or radiotherapy for localized prostate cancer during the prostate-specific antigen era. Int J Radiat Oncol Biol Phys (2002) 1.06
Predictors of mortality after androgen-deprivation therapy in patients with rapidly rising prostate-specific antigen levels after local therapy for prostate cancer. Cancer (2006) 1.04
Bladder cancer. Clinical guidelines in oncology. J Natl Compr Canc Netw (2006) 1.04
Active surveillance for renal angiomyolipoma: outcomes and factors predictive of delayed intervention. BJU Int (2014) 1.03
Correlation between loss of renal function and loss of renal volume after partial nephrectomy for tumor in a solitary kidney. J Urol (2008) 1.03
Comparison of CT findings in symptomatic and incidentally discovered pheochromocytomas. AJR Am J Roentgenol (2005) 1.01
Renal function assessment in the era of chronic kidney disease: renewed emphasis on renal function centered patient care. J Urol (2009) 0.98
Late genitourinary and gastrointestinal toxicity after magnetic resonance image-guided prostate brachytherapy with or without neoadjuvant external beam radiation therapy. Cancer (2003) 0.97
Penile cancer: Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw (2013) 0.97
Imaging in practice. A patient with acute flank pain. Cleve Clin J Med (2005) 0.95
Development of a "reverse capture" autoantibody microarray for studies of antigen-autoantibody profiling. Proteomics (2006) 0.95
Surgical apgar outcome score: perioperative risk assessment for radical cystectomy. J Urol (2009) 0.93
Blood-based biomarkers of aggressive prostate cancer. PLoS One (2012) 0.92
Surgical approach to gastroesophageal reflux disease: what the radiologist needs to know. Radiographics (2005) 0.92
Bladder cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw (2005) 0.91
Comparison of four embolic materials at uterine artery embolization by using postprocedural MR imaging enhancement. Radiology (2009) 0.91
Unraveling androgen receptor interactomes by an array-based method: discovery of proto-oncoprotein c-Rel as a negative regulator of androgen receptor. Exp Cell Res (2006) 0.90
Low-dose rapamycin (sirolimus) effects in autosomal dominant polycystic kidney disease: an open-label randomized controlled pilot study. Clin J Am Soc Nephrol (2014) 0.90
Morbidity of open retroperitoneal lymph node dissection for testicular cancer: contemporary perioperative data. BJU Int (2009) 0.89
Utility of magnetic resonance imaging in anorectal disease. World J Gastroenterol (2007) 0.89
Gastroesophageal reflux disease: integrating the barium esophagram before and after antireflux surgery. Radiology (2007) 0.89
Prostate carcinoma tissue proteomics for biomarker discovery. Cancer (2003) 0.89
Can high-attenuation renal cysts be differentiated from renal cell carcinoma at unenhanced CT? Radiology (2007) 0.89
Angiomyolipoma with minimal fat on MDCT: can counts of negative-attenuation pixels aid diagnosis? AJR Am J Roentgenol (2009) 0.89
PSA outcome following radical prostatectomy for patients with localized prostate cancer stratified by prostatectomy findings and the preoperative PSA level. Urol Oncol (2005) 0.88
Predictors of short postoperative prostate-specific antigen doubling time for patients diagnosed during PSA era. Urology (2005) 0.88
Analysis of changes in attenuation of proven renal cysts on different scanning phases of triphasic MDCT. AJR Am J Roentgenol (2004) 0.87
Detection of hepatic steatosis on contrast-enhanced CT images: diagnostic accuracy of identification of areas of presumed focal fatty sparing. AJR Am J Roentgenol (2012) 0.87
Variations in surgeon volume and use of pelvic lymph node dissection with open and minimally invasive radical prostatectomy. Urology (2008) 0.86
Retroperitoneal liposarcoma. J Urol (2012) 0.86
Maximal tumor diameter and the risk of PSA failure in men with specimen-confined prostate cancer. Urology (2005) 0.86
Safety and efficacy of sonographic-guided random real-time core needle biopsy of the liver. J Clin Ultrasound (2009) 0.85
Using PSA, biopsy Gleason score, clinical stage, and the percentage of positive biopsies to identify optimal candidates for prostate-only radiation therapy. Int J Radiat Oncol Biol Phys (2002) 0.85
Radical prostatectomy reigns supreme. Oncology (Williston Park) (2009) 0.85
The role of computerized tomographic urography in the initial evaluation of hematuria. J Urol (2007) 0.85
Case 135: presacral myelolipoma. Radiology (2008) 0.85
Intravenous iodinated contrast agents: risks and problematic situations. Cleve Clin J Med (2007) 0.84
The gallbladder: uncommon gallbladder conditions and unusual presentations of the common gallbladder pathological processes. Abdom Imaging (2015) 0.84
Adrenal gland and adrenal mass calcification. Eur Radiol (2004) 0.83
Autoantibody signatures as biomarkers to distinguish prostate cancer from benign prostatic hyperplasia in patients with increased serum prostate specific antigen. Clin Chim Acta (2011) 0.83
Computed tomography diagnosis utilizing compressed image data: an ROC analysis using acute appendicitis as a model. J Digit Imaging (2002) 0.83
MR imaging evaluation of myocardial viability in the setting of equivocal SPECT results with (99m)Tc sestamibi. Radiology (2003) 0.82
A native antigen "reverse capture" microarray platform for autoantibody profiling of prostate cancer sera. Proteomics Clin Appl (2007) 0.82
ACR Appropriateness Criteria® posttreatment follow-up of prostate cancer. J Am Coll Radiol (2011) 0.82
Isotropic 3D T2-weighted MR cholangiopancreatography with parallel imaging: feasibility study. AJR Am J Roentgenol (2006) 0.82
Paraperitoneal ureteroinguinal hernia. J Urol (2013) 0.81
Percutaneous access to upper pole renal stones: role of prone 3-dimensional computerized tomography in inspiratory and expiratory phases. J Urol (2005) 0.81
Invasion of seminal vesicles by adenocarcinoma of the prostate: PSA outcome determined by preoperative and postoperative factors. Urology (2004) 0.81
Cardiac herniation after right pneumonectomy: case report and review of the literature. J Thorac Imaging (2007) 0.80
Incidental pheochromocytoma mimicking adrenal adenoma because of rapid contrast enhancement loss. AJR Am J Roentgenol (2006) 0.80
Retroperitoneal lymph node dissection in patients with high risk testicular cancer. J Urol (2009) 0.80